Jazz Pharmaceuticals
JAZZ
#2282
Rank
S$8.23 B
Marketcap
$135.55
Share price
3.03%
Change (1 day)
-8.55%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2024 (TTM): S$0.62 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are S$4.06 Billion. , an increase over its 2023 earnings that were of S$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 S$0.61 B57.87%
2023 S$0.39 B-179.92%
2022 -S$0.49 Billion230.37%
2021 -S$0.15 Billion-141.02%
2020 S$0.36 B-39.45%
2019 S$0.59 B-14.2%
2018 S$0.69 B20.03%
2017 S$0.57 B-17.15%
2016 S$0.69 B22.14%
2015 S$0.57 B187.64%
2014 S$0.19 B-50.79%
2013 S$0.40 B73.63%
2012 S$0.23 B41.69%
2011 S$0.16 B116.61%
2010 S$75.77 M262.77%
2009 S$20.88 M-111.33%
2008 -S$0.19 Billion1.31%
2007 -S$0.19 Billion77.8%
2006 -S$0.11 Billion36.59%
2005 -S$74.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$3.14 Billion-608.54%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$2.74 B 345.78%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.88 B 2,799.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-S$0.37 Billion-159.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel